Trial Profile
A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2023
Price :
$35
*
At a glance
- Drugs Clonidine (Primary)
- Indications Sciatica
- Focus Registrational; Therapeutic Use
- Acronyms RePRIEVE-CM
- Sponsors Sollis Therapeutics
- 05 Oct 2023 Status changed from recruiting to completed.
- 09 Nov 2019 Planned End Date changed from 1 Mar 2021 to 31 Mar 2022.
- 09 Nov 2019 Planned primary completion date changed from 1 Nov 2020 to 30 Nov 2021.